Barclays Downgrades Diplomat Pharmacy to Equal-Weight, Lowers Price Target to $3

Barclays downgrades Diplomat Pharmacy (NYSE:DPLO) from Overweight to Equal-Weight and lowers the price target from $7 to $3.

Benzinga · 11/13/2019 11:50

Barclays downgrades Diplomat Pharmacy (NYSE:DPLO) from Overweight to Equal-Weight and lowers the price target from $7 to $3.